Remote Observational Research for Multiple Sclerosis
A Natural Experiment
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 7, 2022
- Accepted in final form April 10, 2022
- First Published December 30, 2022.
Author Disclosures
- Riley Bove, MD,
- Shane Poole, BS,
- Richard Cuneo, MD,
- Sasha Gupta, MD,
- Joseph Sabatino Jr, MD, PhD,
- Meagan Harms, BA,
- Tifffany Cooper, BA,
- William Rowles, BA,
- Nicolette Miller, BS,
- Refujia Gomez, BA,
- Robin Lincoln, BS,
- Kira McPolin, BA,
- Kyra Powers, BA,
- Adam Santaniello, PhD,
- Adam Renschen, BS,
- Carolyn J. Bevan, MD, MS,
- Jeffrey M. Gelfand, MD, MAS,
- Douglas S. Goodin, MD,
- Chu-Yueh Guo, MD,
- Andrew R. Romeo, MD,
- Stephen L. Hauser, MD and
- Bruce Anthony Campbell Cree, MD, PhD on behalf of the UCSF MS-EPIC Team
- Riley Bove, MD,
(1) Sanofi Genzyme<br><br><br><br>(2) Novartis<br><br><br><br>(3) EMD Serono<br><br><br><br>(4) Alexion<br><br><br><br>(5) TG Therapeutics<br><br><br><br>(6) Janssen<br><br><br><br>(7) Horizon
NONE
None
NONE
NONE
NONE
NONE
(1) Sanofi Genzyme<br><br><br><br>(2) Novartis<br><br><br><br>(3) EMD Serono<br><br><br><br>(4) Alexion<br><br><br><br>(5) Horizon<br><br><br><br>(6) TG Therapeutics<br><br><br><br>(7) Janssen
NONE
NONE
NONE
(1) Commercial entity, F Hoffmann Laroche<br><br><br><br>(2) Commercial entity, Biogen<br><br><br><br>(3) Commercial entity, Novartis
NIH NLM R01LM013396 Sep 1, 2021 - May 31, 2025<br><br><br><br>Role: PI<br><br><br><br><br><br><br><br>DOD MSRP CTA Award 2022-2025
(1) UCSF Medical staff (10/2015-current)
(1) National MS Society, Career Transition Award<br><br><br><br>(2) National MS Society, Research Award<br><br><br><br>(3) National MS Society, Harry Weaver Award
NONE
NONE
NONE
NONE
NONE
NONE
- Shane Poole, BS,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Richard Cuneo, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Sasha Gupta, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Husband received funding for his PhD work from NASA
NONE
I received funding from my fellowship from the National MS <br>Society and Alpha-Stem Cell-CIRM foundation.
NONE
NONE
NONE
NONE
NONE
NONE
- Joseph Sabatino Jr, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Novartis Pharmaceuticals<br>Roche/Genentech
NIH, K08NS107619, PI, year 4
NONE
National Multiple Sclerosis society, TA-1903-33713 and RG-<br>2110-38434
NONE
NONE
NONE
NONE
NONE
NONE
- Meagan Harms, BA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Tifffany Cooper, BA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- William Rowles, BA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Nicolette Miller, BS,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Refujia Gomez, BA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Robin Lincoln, BS,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Kira McPolin, BA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Kyra Powers, BA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Adam Santaniello, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Adam Renschen, BS,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Carolyn J. Bevan, MD, MS,
Ad board for Genentech
NONE
(1) Genentech - compensated travel for speaking at a <br><br><br><br>conference.
NONE
NONE
NONE
NONE
NONE
(1) Genentech
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Jeffrey M. Gelfand, MD, MAS,
DSMB for a National Institutes of Aging funded study. Service on trial steering <br>committees for Genentech/Roche.
NONE
None
Dr. Gelfand is on the editorial advisory board of Neurology: Neuroimmunology & <br><br>Neuroinflammation. Dr. Gelfand's spouse is Editor-in-Chief of Headache and <br><br>previously served on the editorial team of JAMA Neurology.
NONE
Honoraria from UpToDate (Dr. Gelfand and spouse)
NONE
Consulting for Biogen. His spouse has received prior consulting fees from <br><br>Biohaven, Advanced Clinical, Theranica, and Satsuma.
NONE
NONE
NONE
Research support to University of California, San Francisco from Genentech / <br>Roche and Vigil Neuroscience. His spouse has received grant support from <br>Amgen.
NONE
NONE
PI of an Institutional Clinician Training Award from the National MS Society.
NONE
NONE
NONE
NONE
NONE
Dr. Gelfand has received compensation for medical-legal consulting as an expert <br>witness, including for the United States Vaccine Injury Compensation Program.
- Douglas S. Goodin, MD,
None
NONE
Occasional community lectures, symposia and/or<br><br><br><br>academic talks sponsored by (1) Horizon, <br><br><br><br>(2) Biogen. In many cases, travel costs were reimbursed.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Novartis
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Chu-Yueh Guo, MD,
(1) Serving on a scientific advisory board for Genentech
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Andrew R. Romeo, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIH-NINDS, U01 NS106670, investigator, 2021-present
NONE
(1) National Multiple Sclerosis Society (Institutional <br>Clinical Training Award)
NONE
NONE
NONE
NONE
NONE
NONE
- Stephen L. Hauser, MD and
Serves on scientific advisory board for (1) Accure, (2) <br>Alector, and (3) Annexon; serves on Board of Directors <br>for (4) Neurona.
NONE
None
NONE
NONE
(1) Harrison's Principles of Internal Medicine,<br>McGraw-Hill Education
NONE
(1) NGM Bio
NONE
(1) F. Hoffmann La Roche, (2) Novartis AG; travel <br>reimbursement and writing support for anti-CD20 related <br>meetings and presentations.
NONE
NONE
(1) NIH, R35NS111644, PI
NONE
(1) Valhalla Foundation
Stock options received for service on board of directors <br>for (1) Neurona
NONE
NONE
NONE
Stock options received for service on scientific advisory <br>board for (1) Accure, (2) Alector, (3) Annexon
NONE
- Bruce Anthony Campbell Cree, MD, PhD on behalf of the UCSF MS-EPIC Team
Data safety monitoring board: Immunic AG
NONE
None
NONE
NONE
NONE
NONE
Alexion, Atara, Autobahn, Avotres, Biogen, Boston Pharma, EMD Serono, <br>Gossamer Bio, Hexal/Sandoz, Horizon, Neuron23, Novartis, Sanofi, Siemens, TG <br>Therapeutics
NONE
NONE
NONE
Genentech
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the UCSF Weill Institute for Neuroscience, Division of Neuroimmunology and Glial Biology, Department of Neurology, University of California San Francisco, San Francisco, CA.
- Correspondence
Dr. Bove riley.bove{at}ucsf.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
- No related articles found.